Dihydromyricetin Attenuates Diabetic Cardiomyopathy by Inhibiting Oxidative Stress, Inflammation and Necroptosis via Sirtuin 3 Activation
Dihydromyricetin (DHY), the main flavonoid component in <i>Ampelopsis grossedentata</i>, has important benefits for health. The present study aimed to investigate the exact effects and possible mechanisms of DHY on diabetic cardiomyopathy (DCM). Male C57BL/6 mice and sirtuin 3 (SIRT3) kn...
Main Authors: | Yun Chen, Yangyang Zheng, Ruixiang Chen, Jieru Shen, Shuping Zhang, Yunhui Gu, Jiahai Shi, Guoliang Meng |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-01-01
|
Series: | Antioxidants |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-3921/12/1/200 |
Similar Items
-
Dihydromyricetin regulates RIPK3-CaMKII to prevent necroptosis in high glucose-stimulated cardiomyocytes
by: Linlin Sun, et al.
Published: (2024-04-01) -
Dihydromyricetin ameliorates myocardial glucose absorption and glycolysis in mice with diabetic cardiomyopathy
by: DONG Niu, et al.
Published: (2023-04-01) -
Dihydromyricetin attenuates inflammation through TLR4/NF-kappaB pathway
by: Jing Nianshui, et al.
Published: (2019-09-01) -
Dihydromyricetin supplementation improves ethanol-induced lipid accumulation and inflammation
by: Isis Janilkarn-Urena, et al.
Published: (2023-08-01) -
Prognostic signature and therapeutic drug identification for dilated cardiomyopathy based on necroptosis via bioinformatics and experimental validation
by: Han Yang, et al.
Published: (2025-01-01)